HT
ARKG icon

HAP Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

HAP Trading’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,700
Closed -$4K – 1164
2022
Q4 		$4K Sell
22,700
-7,300
-24% -$232K ﹤0.01% 1261
2022
Q3 		$9K Sell
30,000
-800
-3% -$29.4K ﹤0.01% 1339
2022
Q2 		$15K Buy
30,800
+7,000
+29% +$245K ﹤0.01% 1385
2022
Q1 		$17K Sell
23,800
-6,400
-21% -$305K ﹤0.01% 1628
2021
Q4 		$44K Sell
30,200
-49,400
-62% -$3.42M ﹤0.01% 1531
2021
Q3 		$32K Sell
79,600
-19,700
-20% -$1.65M ﹤0.01% 1652
2021
Q2 		$288K Buy
99,300
+11,500
+13% +$978K 0.01% 853
2021
Q1 		$201K Sell
87,800
-53,400
-38% -$5.3M 0.01% 769
2020
Q4 		$445K Buy
+141,200
New +$11.2M 0.01% 663

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

HAP Trading's ARKG Position: Q1 2023 in Review

HAP Trading sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 15,502 shares — an estimated $438K sold.

HAP Trading first reported a position in ARKG in Q3 2019 and held it in 5 quarters. The position peaked at $2.27M in Q2 2021. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • HAP Trading reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
  • HAP Trading sold 15,502 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $438K.
  • HAP Trading first reported a position in ARK Genomic Revolution ETF in Q3 2019 and held it in 5 quarters.
  • HAP Trading's ARK Genomic Revolution ETF position peaked at $2.27M in Q2 2021.
  • 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on HAP Trading's 13F filing for Q1 2023, filed 12 May 2023.